Page 4 - Solution Group Bhd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Solution Group to supply CanSino vaccine in Malaysia A - Solution Group Bhd’s (SGB) wholly-owned subsidiary Solution Biologics Sdn Bhd (Solbio) has signed a finished product and a bulk product agreement today with CanSino Biologics Inc for the supply of the Recombinant Ad5-nCoV vaccine for use against Covid-19. In a statement, the group said the finished product agreement allows Solbio to purchase and CanSino to supply the finish product vaccine for emergency use in Malaysia...

Copy URL The finished product agreement allows Solution Biologics to purchase and CanSino to supply the finished vaccine for emergency use in Malaysia. – AFP pic, July 30, 2021. SOLUTION Group Bhd’s (SGB) wholly owned subsidiary, Solution Biologics Sdn Bhd (Solbio) has signed a finished product and a bulk product agreement today with CanSino Biologics Inc for the supply of the Recombinant Ad5-nCoV vaccine against Covid-19. In a statement, the group said the finished product agreement allows Solbio to purchase and CanSino to supply the finished vaccine for emergency use in Malaysia. Eff...

FILE PHOTO: Vials of a COVID-19 vaccine candidate, a recombinant adenovirus vaccine named Ad5-nCoV, co-developed by Chinese biopharmaceutical firm CanSino Biologics Inc and a team led by Chinese military infectious disease expert, are pictured in Wuhan, Hubei province, China March 24, 2020. China Daily via REUTERS KUALA LUMPUR (Bernama): Solution Group Bhd’s (SGB) wholly-owned subsidiary, Solution Biologics Sdn Bhd (SolBio) has signed a finished product and a bulk product agreement today with CanSino Biologics Inc for the supply of the Recombinant Ad5-nCoV vaccine for use against Covid-1...

has entered into a supply agreement with the Health Ministry to supply Convidicea, a recombinant novel coronavirus vaccine also known as adenovirus type 5 vaccine. In a statement, Solution said its wholly-owned subsidiary Solution Biologics Sdn Bhd (SOLBIO) would supply 3.5 million doses of the vaccine to MOH. The vaccine was jointly developed by CanSino Biologics Inc and Beijing Institute of Biotechnology, Academy of Military Medical Sciences. CanSino has also authorised SOLBIO and granted it the exclusive right to register, manufacture and commercialise the vaccine in Malaysia. “SOLBIO i...

Moderna Inc won approval from Singapore for its Covid vaccine and signed a deal to sell doses to the Philippines, becoming the fourth supplier to get regulatory clearance in Southeast Asia.